Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
Source: yahoo.com